Machine Learning

With a $60M backing from a mystery investor, U Power plans to bring its AI-driven battery swapping tech to Southern Europe. Can it succeed?

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

A new partnership between EcoFlow and Octopus Energy turns homes into automated power stations, slashing bills and reshaping the UK's energy grid.

Hexagon's latest acquisition of AI specialist IconPro signals a major push into predictive maintenance, aiming to redefine manufacturing efficiency.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Beyond a routine board re-election, Heidmar Maritime is doubling down on an AI-driven strategy to navigate the volatile tanker market. Here's what it means.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

Beyond fiber and 5G, the most vital infrastructure is human talent. A new scholarship is empowering the next generation of innovators to build it.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

A new collaboration aims to transform market noise into actionable foresight, moving beyond simple bets to offer a unified view of the global economy.

An ISG report names Rackspace a leader in AI-driven cloud services, revealing how it helps midmarket firms master cost, complexity, and security.

A new law requires work verification for millions on Medicaid. One tech firm has a solution, but can its AI bridge the gap or widen the access divide?

Anixa Biosciences now fully controls its breast cancer vaccine after promising Phase 1 data. What does this strategic move mean for investors and medicine?

Odysight.ai's new sensors offer a live video feed from inside hot, oil-filled machinery, a breakthrough poised to transform industrial predictive maintenance.

Rail Vision just secured a key European patent for its AI collision avoidance tech. Is this IP fortress enough to challenge giants and define the future of rail?